Curaleaf, Trulieve, Cresco Labs, Green Thumb Industries, and Verano lead the rally

  • Cannabis stocks rally on news of recommendation to lower classification
  • Curaleaf, Trulieve, Cresco Labs, Green Thumb Industries, and Verano see significant gains
  • Texas lawyer obtains and publishes 250-page document supporting recommendation
  • HHS report acknowledges credible scientific support for medical use of marijuana
  • Rescheduling cannabis could benefit industry by reducing taxes and opening up interstate trade

The release of documents supporting a recommendation by the U.S. Department of Health and Human Services (HHS) to lower the classification of cannabis from Schedule I to Schedule III sparked a rally in cannabis stocks. Curaleaf, Trulieve, Cresco Labs, Green Thumb Industries, and Verano all saw significant gains. The 250-page document, obtained and published by a Texas lawyer, revealed that there is credible scientific support for the medical use of marijuana. Rescheduling cannabis could have positive implications for the industry, including reducing taxes and opening up interstate trade.

Public Companies: Curaleaf Holdings Inc. (CURLF), Trulieve Cannabis Corp. (TCNNF), Green Thumb Industries Inc. (GTBIF), Cresco Labs Inc. (CRLBF), Verano Holdings Corp. (VRNOF), TerrAscend Corp. (TSNDF)
Private Companies:
Key People:

Track all markets on TradingView

Factuality Level: 7
Justification: The article provides information about the release of documents supporting a recommendation to lower the classification of cannabis under federal law. It includes quotes from industry members and mentions the potential benefits of rescheduling cannabis. However, it lacks in-depth analysis and does not provide a balanced perspective on the topic.

Noise Level: 3
Justification: The article provides relevant information about the release of documents supporting the recommendation to lower the classification of cannabis. It includes details about the rally in cannabis stocks and the conflicts within the DEA. However, it lacks scientific rigor and intellectual honesty as it does not provide in-depth analysis or evidence to support the claims made. It also includes irrelevant information about a cannabis company’s future plans and the CEO’s perspective.

Financial Relevance: Yes
Financial Markets Impacted: The release of documents supporting the recommendation to lower the classification of cannabis could impact cannabis stocks such as Curaleaf Holdings Inc., Trulieve Cannabis Corp., Green Thumb Industries Inc., Cresco Labs Inc., Verano Holdings Corp., TerrAscend Corp., and the AdvisorShares Pure U.S. Cannabis exchange-traded fund MSOS.

Presence of Extreme Event: No
Nature of Extreme Event: No
Impact Rating of the Extreme Event: No
Justification: The article discusses the impact of the release of documents supporting the recommendation to lower the classification of cannabis. While this event does not qualify as an extreme event, it is relevant to financial markets as it affects the cannabis industry and related stocks.

Reported publicly: www.marketwatch.com